[Erythrocyte functional activity in patients with heart failure and the possible means for its correction].
Sakharchuk
I I
II
Sisetskiĭ
A P
AP
Artiukh
V P
VP
Starodub
N F
NF
D000328:Adult; D000368:Aged; D002317:Cardiovascular Agents / Q000627:therapeutic use; D002908:Chronic Disease; D004359:Drug Therapy, Combination; D004912:Erythrocytes / Q000187:drug effects / Q000502:physiology*; D006333:Heart Failure / Q000097:blood* / Q000188:drug therapy / Q000209:etiology; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D008297:Male; D008763:Methylhydrazines / Q000627:therapeutic use; D008875:Middle Aged; D017202:Myocardial Ischemia / Q000097:blood / Q000150:complications / Q000188:drug therapy
D002317:Cardiovascular Agents; D008763:Methylhydrazines; C050147:3-(2,2,2-trimethylhydrazine)propionate
Funktsional'naia aktivnost' éritrotsitov u bol'nykh s serdechnoĭ nedostatochnost'iu i vozmozhnye puti ee korrektsii.